首页 | 本学科首页   官方微博 | 高级检索  
     


Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS‐HF study
Authors:Ken Lee Chin  Timothy J. Collier  Bertram Pitt  John J.V. McMurray  Karl Swedberg  Dirk J. van Veldhuisen  Stuart J. Pocock  John Vincent  Eva Turgonyi  Faiez Zannad  for the EMPHASIS‐HF Study Investigators
Affiliation:1. Centre of Cardiovascular Research & Education in Therapeutics, Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia;2. London School of Hygiene and Tropical Medicine, London, UK;3. University of Michigan School of Medicine, Ann Arbor, MI, USA;4. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK;5. Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden;6. National Heart and Lung Institute, Imperial College, London, UK;7. University of Groningen, Groningen, The Netherlands;8. Pfizer, New York, USA;9. CHU and University Henri Poincaré, Nancy, France
Abstract:
Keywords:Heart failure  Aspirin  Eplerenone  Aldosterone  Bradykinin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号